Atlas Trials

Collecting Duct Carcinoma

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Collecting Duct Carcinoma

RecordFirmDate
Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma (NCT06302569)Giuseppe Procopio2025-05-30
Study to Evaluate the Efficacy and Safety of Immunotherapy With Axitinib in Advanced Collecting Duct Carcinoma (NCT06211114)Peking University Cancer Hospital & Institute2024-02-09
Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer (NCT04603365)Jonsson Comprehensive Cancer Center2021-10-18
Collecting Ducts Carcinoma: in Depth Exploration and Biologically Driven Therapy (CICERONE) (NCT05372302)Fondazione IRCCS Istituto Nazionale dei Tumori, Milano2021-07-08
Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study (NCT04071223)National Cancer Institute (NCI)2020-07-29
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors (NCT03866382)National Cancer Institute (NCI)2019-05-13

Track Collecting Duct Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.